Therapeutic Alliance Tensions and Repair in Psychotherapy Practices
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03453957|
Recruitment Status : Recruiting
First Posted : March 5, 2018
Last Update Posted : March 5, 2018
|Condition or disease||Intervention/treatment||Phase|
|Psychotherapy Therapeutic Alliance||Other: Professional development program||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||80 participants|
|Intervention Model:||Parallel Assignment|
|Intervention Model Description:||This will be a 2-arm, parallel, prospective, single-blind cluster RCT with 1-1 allocation comparing: (a) therapists who receive the professional development intervention to identify and repair alliance tensions at the study outset versus (b) therapists who receive the intervention after participation is complete (no training control). Therapists will be randomized to study condition and patients will be clustered within therapists. Randomization will control for: (a) the effect of therapist variables (age, gender, theoretical orientation, experience, differing initial skill level) on competence, therapeutic alliance, or patient outcomes; (b) potential biases caused by pre-treatment patient variables (symptom severity, co-morbidity, chronicity, psychoactive medications); and (c) treatment or study factors (e.g. frequency of sessions, time to complete the study sessions, treatment received after the study sessions). Patients will be blind to therapist study arm allocation.|
|Masking Description:||Participating therapists will be aware of their group (Professional development training vs no training control); however, their participating patient/clients will not know which experimental group their therapists belongs to.|
|Primary Purpose:||Health Services Research|
|Official Title:||Therapeutic Alliance Tensions and Repair in Psychotherapy Practices: A Psychotherapy Practice Research Network (PPRNet) Study|
|Actual Study Start Date :||February 1, 2018|
|Estimated Primary Completion Date :||August 2019|
|Estimated Study Completion Date :||February 2020|
Experimental: Professional Development Program
Therapists who participate in workshops and consultation sessions with study trainers during study-related therapy sessions and their participating patients/clients.
Other: Professional development program
Professional development program consists of training including workshops and consultation sessions to enhance therapists ability to detect and repair alliance ruptures in active community based psychotherapy.
No Intervention: Control
Therapists who did not participate in workshops and consultations sessions while engaging in study-related therapy sessions and their participating patients/clients.
- Mean tension resolution rating scale [ Time Frame: 6 therapy sessions - 6 weeks ]The Rupture Resolution Rating System (3RS) is an observer-based measure to identify alliance tensions and resolution processes, and strategies therapists might use to resolve alliance tensions. Independent blind reliable trained judges will rate video recordings made during 6 psychotherapy session with participating clients and provide a mean tension resolution score.
- Generalized Anxiety Disorder 7-item scale (GAD-7) change following therapy [ Time Frame: baseline and end of 6 therapy sessions, typically 7 weeks ]Self-report measurement of severity of anxiety using the GAD-7 scale. A change in anxiety scores will be assess following 6 therapy session with data collected before therapy and again after all 6 sessions of therapy have been completed.
- Patient Health Questionnaire 9-item scale (PHQ-9) change following therapy [ Time Frame: baseline and end of 6 therapy sessions, typically 7 weeks ]Self-report measurement of depression symptoms using the PHQ-9 scale. A change in depression symptom scores will be assess following 6 therapy session with data collected before therapy and again after all 6 sessions of therapy have been completed.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03453957
|Contact: Giorgio Tasca, Ph.D.||1-613-562-5800 ext 3890||GTASCA@uottawa.ca|
|Contact: Stephanie Baker, Ph.D.||1-562-5800 ext firstname.lastname@example.org|
|University of Ottawa||Recruiting|
|Ottawa, Ontario, Canada, K1N 6N5|
|Contact: Giorgio Tasca, Ph.D, C.Psych. 1-613-562-5800 ext 3890 GTASCA@uottawa.ca|
|Contact: Stephanie Baker, Ph.D 1-613-562-5800 ext 4218 email@example.com|
|Mt. Sinai Hospital||Recruiting|
|Toronto, Ontario, Canada, M5G 1X5|
|Contact: Paula Ravitz, M.D. Paula.Ravitz@sinaihealthsystems.ca|
|Principal Investigator:||Giorgio Tasca, Ph.D.||University of Ottawa|